During the past decade, Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 55 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 37 clinical trials were completed. i.e. 60.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Celgene" with 10 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Gilead Sciences" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 129 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 3 trials as a collaborator, "Marinella Astuto" with 3 trials as a collaborator, "Agenzia Italiana del Farmaco" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" are "Multiple Myeloma" (10 trials), "Coronary Artery Disease" (7 trials), "Idiopathic Pulmonary Fibrosis" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Myelofibrosis" (5 trials). Many other conditions were trialed in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" are "Drug" (124 trials), "Other" (24 trials), "Device" (17 trials), "Biological" (9 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Dexamethasone" (6 trials), "Docetaxel" (5 trials), "Carboplatin" (4 trials) and "Obinutuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele" are 163 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele". undefined are not yet recruiting, 33 are recruiting, 31 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 81 completed trials in Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, 6 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 10 trials that are defined as “Not Applicable".

Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele has several departments that took part in Clinical trials: "AOU Policlinico V. Emanuele - P.O G. Rodolico; Clinica Neurologica, Centro Sclerosi Multipla" - 7 trials, "Ospedale Ferrarotto" - 36 trials, "Azienda Ospedaliero-Universitaria "PoliclinicoVittorio Emanuele"- P.O. G. Rodolico; Oncologia Medica" - 4 trials, "AOU Policlinico Vittorio Emanuele UOC di Oncologia" - 4 trials, "Ospedale Vittorio Emanuele Ii; U.O. Reumatologia Clinica Medica Condorelli" - 2 trials, "Azienda Policlinico Vittorio Emanuele; Pneumologia Riabilitativa E Allergologia" - 2 trials